Quick Answer
ACCENDRA HEALTH INC/VA/ reported Diluted EPS of $14.31 per share (loss) for fiscal year 2025.
ACCENDRA HEALTH INC/VA/ Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$14.31 | -202.5% |
| 2024 | -$4.73 | -792.5% |
| 2023 | -$0.53 | -282.8% |
| 2022 | $0.29 | -90.1% |
| 2021 | $2.94 | +525.5% |
| 2020 | $0.47 | +145.6% |
| 2019 | -$1.03 | -158.5% |
| 2016 | $1.76 | +6.7% |
| 2015 | $1.65 | +55.7% |
| 2014 | $1.06 | -39.8% |
| 2013 | $1.76 | +2.3% |
| 2012 | $1.72 | -5.0% |
| 2011 | $1.81 | +3.4% |
| 2010 | $1.75 | +4.8% |
| 2009 | $1.67 | +11.3% |
| 2008 | $1.50 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.94 | -1112.5% | +82.8% |
| June 30, 2025 | -$11.30 | -2590.5% | -3431.2% |
| March 31, 2025 | -$0.32 | -10.3% | -100.0% |
| September 30, 2024 | -$0.16 | -100.0% | +61.9% |
| June 30, 2024 | -$0.42 | -13.5% | -44.8% |
| March 31, 2024 | -$0.29 | +9.4% | -262.5% |
| September 30, 2023 | -$0.08 | -150.0% | +78.4% |
| June 30, 2023 | -$0.37 | -200.0% | -15.6% |
- ACCENDRA HEALTH INC/VA/ showed a decrease of -202.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2008–2025 period, ACCENDRA HEALTH INC/VA/’s diluted eps has declined by 1054.0% (from $1.50 per share to $14.31 per share (loss)).
- The most recent figure is from ACCENDRA HEALTH INC/VA/’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: